Trial intelligence / Profile preview

Effect of inhaled sevoflurane mixture during total intravenous anesthesia on motor evoked potentials

jRCT1011220040Not yet recruiting

Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of sevoflurane in brain neoplasm and cerebrovascular disease. Primary endpoint: Rate of successful MEP monitoring. Planned start Feb 2023; status: not yet recruiting.

02

Drugs

sevoflurane
03

Conditions

brain neoplasmcerebrovascular disease

Beyond the preview

Go deeper on jRCT1011220040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1011220040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call